S. Shak

2.5k citations
40 papers · 1.8k · 1 hit paper · h-index 12

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology

Papers in

    • Breast Cancer Treatment Studies 23
    • Cancer Genomics and Diagnostics 11
    • Cancer Treatment and Pharmacology 8
    • HER2/EGFR in Cancer Research 7
    • Colorectal Cancer Treatments and Studies 4

S. Shak

39 papers receiving 1.7k citations

S. Shak's Hit Papers

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer 2001 · 744 citations
7440+8+16Years since publication200400600

Peers

S. Shak
Comparison fields: 5 of 78
  • Cancer Research 749
  • Oncology 1.1k
  • Pathology and Forensic Medicine 255
  • Radiology, Nuclear Medicine and Imaging 302
  • Hepatology 97
Replace Séverine Guiu with:
Séverine Guiu France
Amy P. Sing United States
Maria Pia Brizzi Italy
Carol Peña United States
S. Tjulandin Russia
Neesha C. Dhani Canada
D. F. Hayes United States
Marta Guix Spain
Laia Paré Spain
Marjorie C. Green United States
S. Shak relative to Séverine Guiu France Séverine Guiu's profile →
Citations per field
00.5×1.5×
Séverine Guiu · 1×
Citations per year

Countries citing papers authored by S. Shak

Since Specialization
Citations

This map shows the geographic impact of S. Shak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Shak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Shak more than expected).

Fields of papers citing papers by S. Shak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Shak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Shak. The network helps show where S. Shak may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Shak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Shak Line = papers co-authored together S. Shak links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer
Hit paper breakdown →
2001744
2 2013335
3
Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group.
1999227
4 201091
5 201181
6 200680
7 200925
8 200924
9 202019
10 201219
11 201416
12 200914
13 201011
14 201010
15 20169
16 20049
17 20088
18 20108
19 20046
20
Prospective WSG phase III PlanB trial: Clinical outcome at 5 year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer
20165

About S. Shak

S. Shak is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 40 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Advanced Breast Cancer Therapies (14 papers), Cancer Genomics and Diagnostics (11 papers), Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (7 papers), Molecular Biology Techniques and Applications (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Cancer Research (749 citations), Oncology (1.1k citations), Pathology and Forensic Medicine (255 citations), Radiology, Nuclear Medicine and Imaging (302 citations) and Hepatology (97 citations). S. Shak has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include George W. Sledge, Kim Margolin, Michael S. Gordon, Robert S. Benjamin, Daniel C. Adelman, Moshe Talpaz, Eric Holmgren, Frederick L. Baehner, Carl Yoshizawa and G. W. Sledge. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, European Journal of Cancer and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact